Alberto Piubello - Publications

Prioritizing research topics identified by end-users for a successful and rapid uptake of new tuberculosis treatment regimens.

Journal: The European respiratory journal

Published: May 05, 2026

Breaking barriers in extensively drug-resistant TB: pretomanid-centred long regimen achieves cure in a bedaquiline-resistant strain.

Journal: IJTLD open

Published: January 30, 2026

Feasibility and efficacy of a population-based pulmonary rehabilitation for post-tuberculosis lung disease in Bangladesh.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: January 19, 2026

Fifteen years of rifampicin-resistant TB control in Niger: high countrywide treatment uptake and success.

Journal: IJTLD open

Published: July 07, 2025

Yield of community outreach events for TB screening.

Journal: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease

Published: June 11, 2025

Using linezolid as a substitute for the injectable in case of ototoxicity is safer and as effective as all-oral treatment for rifampicin-resistant TB.

Journal: IJTLD open

Published: February 28, 2025

Management of individuals exposed to multidrug-resistant or rifampicin-resistant tuberculosis.

Journal: The Lancet. Infectious diseases

Published: November 25, 2024

Impact of COVID-19 on diagnosis of tuberculosis and tuberculosis infection in South America, Asia, and Africa.

Journal: Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia

Published: July 10, 2024

Risk factors for rifampicin resistance tuberculosis among patients attending Directly Observed Treatments Centres in Southwestern Nigeria.

Journal: The Pan African medical journal

Published: May 15, 2024

Feasibility and accuracy of mobile QT interval monitoring strategies in bedaquiline-enhanced prophylactic leprosy treatment.

Journal: Clinical and translational science

Published: April 02, 2024

Safety of single-dose bedaquiline combined with rifampicin for leprosy post-exposure prophylaxis: A Phase 2 randomized non-inferiority trial in the Comoros Islands.

Journal: PLoS medicine

Published: December 12, 2023

Protocol, rationale and design of BE-PEOPLE (Bedaquiline enhanced exposure prophylaxis for LEprosy in the Comoros): a cluster randomized trial on effectiveness of rifampicin and bedaquiline as post-exposure prophylaxis of leprosy contacts.

Journal: BMC infectious diseases

Published: March 24, 2023